Self-Hypnosis for the Enhanced Recovery After Surgery in Patients With Gynecologic Cancer
Integration of Self-Hypnosis in an Enhanced Recovery After Surgery (ERAS) Program: A Prospective Randomized Trial
2 other identifiers
interventional
152
1 country
1
Brief Summary
This trial studies how well self-hypnosis works in enhancing recovery after surgery in patients with gynecologic cancer. A guided relaxation method called self-hypnosis may help affect how patients feel pain and symptoms after surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 11, 2018
CompletedFirst Submitted
Initial submission to the registry
December 30, 2019
CompletedFirst Posted
Study publicly available on registry
February 12, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
March 13, 2026
March 1, 2026
9.3 years
December 30, 2019
March 11, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Feasibility of participating in pre-operative self-hypnosis
Will assess proportion of participants who listen to the complete audio file in the preoperative holding area.
Up to 1 day
Patients' perception of post-surgical pain
Will summarize POD1 pain scores for each treatment arm using descriptive statistics. Will use a Wilcoxon rank sums test to determine if the POD1 pain scores in the self-hypnosis arm are lower than the usual care arm. Pain intensity score from 0 to 10.
Post-operative day 1 (POD1)
Study Arms (2)
Arm I (usual care)
ACTIVE COMPARATORPatients receive usual care including receipt of multi-modal analgesia and the injection of a local analgesic at the time of surgery on the ERAS pathway.
Arm II (usual care, self-hypnosis guided relaxation)
EXPERIMENTALPatients receive usual care as in Arm I. Patients also receive self-hypnosis guided relaxation by listening to MP3 on the ERAS pathway.
Interventions
Receive usual care
Receive self-hypnosis guided relaxation
Ancillary studies
Ancillary studies
Eligibility Criteria
You may qualify if:
- Undergoing an exploratory laparotomy for suspected gynecologic cancer, which includes metastatic disease from neoplasia originating in other organs
- Planned participation in the Gynecologic Enhanced Recovery Pathway
- Patient must be able to read, understand, and speak English
- Consents to being part of a randomized study
- Patient has physical and mental capabilities to take part in study
You may not qualify if:
- Sensitivity to amide-type local anesthetics
- Patients on long-acting opioid medications, or scheduled (four or more times a day for seven or more days) short-acting opioid medications within the last 30 days
- Emergency surgery of any type that does not allow for proper time for protocol review by the patient
- Surgery that involves known/anticipated resection of anterior abdominal wall with plastic surgery reconstruction
- Patients undergoing known/anticipated anterior abdominal wall hernia repairs
- Patients undergoing pelvic exenteration
- Patients with known major psychiatric disease
- Patients with hearing impairment such that they are unable to hear the intervention
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- M.D. Anderson Cancer Centerlead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Larissa A Meyer
M.D. Anderson Cancer Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 30, 2019
First Posted
February 12, 2020
Study Start
September 11, 2018
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
March 13, 2026
Record last verified: 2026-03